Literature DB >> 2267212

Thrombotic thrombocytopenic purpura with terminal pancytopenia.

S C Ng1, B A Adam.   

Abstract

A 27 year old housewife developed thrombotic thrombocytopenic purpura during the twelfth week of pregnancy. She had partial response to initial plasma infusion and subsequent plasmapheresis. However, her clinical course was complicated by the development of severe pancytopenia the consequence of a hypocellular marrow. She succumbed to septicaemic shock one month after diagnosis. The development of hypocellular marrow in thrombotic thrombocytopenic purpura has not been reported before.

Entities:  

Mesh:

Year:  1990        PMID: 2267212      PMCID: PMC2429757          DOI: 10.1136/pgmj.66.781.955

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  Treatment of thrombotic thrombocytopenic purpura with plasma.

Authors:  J J Byrnes; M Khurana
Journal:  N Engl J Med       Date:  1977-12-22       Impact factor: 91.245

2.  Thrombotic thrombocytopenic purpura. A reappraisal.

Authors:  S M Crain; A M Choudhury
Journal:  JAMA       Date:  1981-09-11       Impact factor: 56.272

Review 3.  Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature.

Authors:  R L Ridolfi; W R Bell
Journal:  Medicine (Baltimore)       Date:  1981-11       Impact factor: 1.889

4.  Thrombotic thrombocytopenic purpura in early pregnancy. Remission after plasma exchange.

Authors:  C Yang; M Nussbaum; H Park
Journal:  Acta Haematol       Date:  1979       Impact factor: 2.195

Review 5.  Human posttransfusion graft-versus-host disease.

Authors:  D B Brubaker
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

6.  Thrombotic thrombocytopenic purpura: treatment with plasmapheresis.

Authors:  J B Blitzer; J M Granfortuna; A J Gottlieb; J R Smith; M E Theodorakis; K W Zamkoff; S A Landaw; J Goldberg; A J Scalzo; H Lamberson
Journal:  Am J Hematol       Date:  1987-04       Impact factor: 10.047

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.